642 related articles for article (PubMed ID: 32607773)
1. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
Ferrante ND; Lo Re V
Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis D: A Review.
Negro F; Lok AS
JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
[TBL] [Abstract][Full Text] [Related]
3. HBV/HDV Coinfection: A Challenge for Therapeutics.
Koh C; Da BL; Glenn JS
Clin Liver Dis; 2019 Aug; 23(3):557-572. PubMed ID: 31266627
[TBL] [Abstract][Full Text] [Related]
4. Treatment of delta hepatitis.
Gunsar F
Expert Rev Anti Infect Ther; 2013 May; 11(5):489-98. PubMed ID: 23627855
[TBL] [Abstract][Full Text] [Related]
5. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
[TBL] [Abstract][Full Text] [Related]
6. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
[TBL] [Abstract][Full Text] [Related]
7. Non-F HBV/HDV-3 coinfection is associated with severe liver disease in Western Brazilian Amazon.
Melo Da Silva E; Kay A; Lobato C; Muwonge R; Zoulim F; Brites C; Parana R; Trepo C
J Med Virol; 2019 Jun; 91(6):1081-1086. PubMed ID: 30695106
[TBL] [Abstract][Full Text] [Related]
8. Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Anderson M; Gersch J; Holzmayer V; Elsner C; Krawczyk A; Kuhns MC; Cloherty G; Dittmer U; Vaillant A
Hepatol Commun; 2021 Feb; 5(2):189-202. PubMed ID: 33553968
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States.
Ferrante ND; Kallan MJ; Sukkestad S; Kodani M; Kitahata MM; Cachay ER; Bhattacharya D; Heath S; Napravnik S; Moore RD; Yendewa G; Mayer KH; Reddy KR; Hayden T; Kamili S; Martin JN; Kim HN; Lo Re V
J Viral Hepat; 2023 Nov; 30(11):879-888. PubMed ID: 37488783
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis delta and HIV infection.
Soriano V; Sherman KE; Barreiro P
AIDS; 2017 Apr; 31(7):875-884. PubMed ID: 28121714
[TBL] [Abstract][Full Text] [Related]
11. Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California.
Gish RG; Yi DH; Kane S; Clark M; Mangahas M; Baqai S; Winters MA; Proudfoot J; Glenn JS
J Gastroenterol Hepatol; 2013 Sep; 28(9):1521-5. PubMed ID: 23574043
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hepatitis delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region.
Saravanan S; Madhavan V; Velu V; Murugavel KG; Waldrop G; Solomon SS; Balakrishnan P; Kumarasamy N; Smith DM; Mayer KH; Solomon S; Thyagarajan SP
J Int Assoc Provid AIDS Care; 2014; 13(1):85-90. PubMed ID: 23722085
[TBL] [Abstract][Full Text] [Related]
13. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
[TBL] [Abstract][Full Text] [Related]
14. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
Goyal A; Murray JM
Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
[TBL] [Abstract][Full Text] [Related]
16. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
Lutterkort GL; Wranke A; Hengst J; Yurdaydin C; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Manns MP; Dienes HP; Falk C; Wedemeyer H; Heidrich B
J Viral Hepat; 2018 Nov; 25(11):1384-1394. PubMed ID: 29888837
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
[TBL] [Abstract][Full Text] [Related]
18. Innate immune recognition and modulation in hepatitis D virus infection.
Jung S; Altstetter SM; Protzer U
World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of hepatitis D virus infection in Europe: Is it vanishing?
Demirel A; Uraz S; Deniz Z; Daglilar E; Basar O; Tahan V; Ozaras R
J Viral Hepat; 2024 Feb; 31(2):120-128. PubMed ID: 37964693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]